GE HealthCare Technologies Inc. (GEHC) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.66x

GE HealthCare Technologies Inc. (GEHC) has a Cash Flow Reinvestment Rate of 0.66x as of March 2026, reinvesting $191.00 Million (capex $178.00 Million plus investments $-13.00 Million) from operating cash flow of $290.00 Million. Explore GE HealthCare Technologies Inc. (GEHC) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.66x
(Capex + Investments) / Operating CF

Total Reinvested

$191.00 Million
Capex + Investments

Operating Cash Flow

$290.00 Million
USD

Capital Expenditures

$178.00 Million
USD

GE HealthCare Technologies Inc. Cash Flow Reinvestment Rate (2019–2025)

Historical reinvestment intensity for GE HealthCare Technologies Inc. across 7 annual periods. Also explore GE HealthCare Technologies Inc. assets under control for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for GE HealthCare Technologies Inc. (2019–2025)

Year-by-year capital reinvestment analysis for GE HealthCare Technologies Inc.. For live market cap and broader valuation context, see GE HealthCare Technologies Inc. stock valuation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.30x $600.00 Million $1.99 Billion $482.00 Million ▼ -55.2%
2024 0.67x $1.31 Billion $1.95 Billion $401.00 Million ▲ +49.9%
2023 0.45x $945.00 Million $2.10 Billion $387.00 Million ▲ +34.2%
2022 0.34x $708.00 Million $2.11 Billion $310.00 Million ▼ -73.2%
2021 1.25x $2.01 Billion $1.61 Billion $248.00 Million ▼ -89.6%
2020 12.00x $20.25 Billion $1.69 Billion $259.00 Million ▲ +3538.6%
2019 0.33x $656.00 Million $1.99 Billion $331.00 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow